Literature DB >> 28898552

A key tyrosine substitution restricts nucleotide hydrolysis by the ectoenzyme NPP5.

Alexei Gorelik1, Antsa Randriamihaja1, Katalin Illes1, Bhushan Nagar1.   

Abstract

The ecto-nucleotide pyrophosphatase/phosphodiesterase (NPP) family of proteins mediates purinergic signaling by degrading extracellular nucleotides and also participates in phospholipid metabolism. NPP5 (ENPP5) is the least characterized member of this group and its specific role is unknown. This enzyme does not display activity on certain nucleotides and on other typical NPP substrates. In order to gain insights into its function, we determined the crystal structure of human and murine NPP5. Structural comparison with close homologs revealed a key phenylalanine to tyrosine substitution that prevents efficient hydrolysis of nucleotide diphosphates and triphosphates; reversal of this mutation enabled degradation of these molecules. Interestingly, NPP5 is able to cleave nicotinamide adenine dinucleotide (NAD), suggesting a potential role of this enzyme in NAD-based neurotransmission. An NPP5-specific metal binding motif is found adjacent to the active site, although its significance is unclear. These findings expand our understanding of substrate specificity within the NPP family. DATABASE: Structural data are available in the Protein Data Bank under the accession numbers 5VEM, 5VEN, and 5VEO.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  nicotinamide adenine dinucleotide; nucleotide; phosphodiesterase; purinergic signaling; zinc

Mesh:

Substances:

Year:  2017        PMID: 28898552     DOI: 10.1111/febs.14266

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Purification, crystallization and crystallographic analysis of the PorX response regulator associated with the type IX secretion system.

Authors:  Anshu Saran; Nuwani Weerasinghe; Christopher J Thibodeaux; Natalie Zeytuni
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-09-26       Impact factor: 1.072

2.  Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.

Authors:  Sang-Yong Lee; Vigneshwaran Namasivayam; Nader M Boshta; Arianna Perotti; Salahuddin Mirza; Silvia Bua; Claudiu T Supuran; Christa E Müller
Journal:  RSC Med Chem       Date:  2021-06-16

3.  Crystal structure and substrate binding mode of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3).

Authors:  Christoph Döhler; Matthias Zebisch; Norbert Sträter
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

4.  The essential schistosome tegumental ectoenzyme SmNPP5 can block NAD-induced T cell apoptosis.

Authors:  Catherine S Nation; Akram A Da'Dara; Patrick J Skelly
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

5.  Sulfated Polysaccharides from Macroalgae Are Potent Dual Inhibitors of Human ATP-Hydrolyzing Ectonucleotidases NPP1 and CD39.

Authors:  Vittoria Lopez; Laura Schäkel; H J Maximilian Schuh; Michael S Schmidt; Salahuddin Mirza; Christian Renn; Julie Pelletier; Sang-Yong Lee; Jean Sévigny; Susanne Alban; Gerd Bendas; Christa E Müller
Journal:  Mar Drugs       Date:  2021-01-22       Impact factor: 5.118

6.  Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis.

Authors:  Gábor Fidler; Anna Anita Szilágyi-Rácz; Péter Dávid; Emese Tolnai; László Rejtő; Róbert Szász; Szilárd Póliska; Sándor Biró; Melinda Paholcsek
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

7.  Automatically Fixing Errors in Glycoprotein Structures with Rosetta.

Authors:  Brandon Frenz; Sebastian Rämisch; Andrew J Borst; Alexandra C Walls; Jared Adolf-Bryfogle; William R Schief; David Veesler; Frank DiMaio
Journal:  Structure       Date:  2018-10-18       Impact factor: 5.006

8.  Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity.

Authors:  Anna Wilk; Faisal Hayat; Richard Cunningham; Jianfeng Li; Silvia Garavaglia; Leila Zamani; Davide M Ferraris; Peter Sykora; Joel Andrews; Jennifer Clark; Amanda Davis; Laurent Chaloin; Menico Rizzi; Marie Migaud; Robert W Sobol
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.